New research demonstrated that patients using a digital treatment for nonspecific low back pain report significantly stronger pain reduction compared to their peers receiving the standard of care.
The cluster-randomized study, published in the Journal of Pain Research, compared patients using traditional treatment methods to those using a digital program called Rise-uP, which combined electronic...
Digital chronic-disease-program company Omada Health is leaping into musculoskeletal care thanks to its acquisition of Physera, an app-based platform that includes remote consultations with physical therapists.
Although the deal was announced today, Omada said it will "immediately" begin offering the MSK program to its employer, health plan and individual customers.
“Integrating a digital...
This morning digital physical therapy program Sword Health announced that it scored $9 million in the second phase of its Series A funding round, which brings the round's total to $17 million. Khosla Ventures led with participation from Founders Fund, Green Innovations, Lachy Groom, Vesalius Biocapital and Faber Ventures.
This news comes roughly a year after the startup announced the $8 million...
Hinge Health, the maker of digital programs for chronic musculoskeletal (MSK) health, has closed $90 million in a new round led by Bessemer Venture Partners. Lead Edge Capital also took part in the Series C, as did prior backers Insight Partners, Atomico, 11.2 Capital, Quadrille Capital and Heuristic Capital.
Hinge had been courting investors throughout the course of the last quarter, and...
Physera — an app-based platform for musculoskeletal (MSK) exercises and remote consultations with physical therapists — has raised $8 million in a Series A round headed by BlueCross BlueShield Venture Partners.
With this, the company has now raised more than $10 million in total, and counts Innovation Endeavors, Lux Capital, Expa, Slow Ventures, iD Ventures, J-Angels, Rock Health’s Halle Tecco...
Paige.AI, a health technology company that applies artificial intelligence to pathology for cancer diagnosis and treatment, recently announced it landed $25 million in Series A funding, led by Jim Breyer of Breyer Capital.
“Patients deserve and need an accurate diagnosis as quickly as possible, yet our current methods are time-consuming, expensive and subjective,” Dr. David Klimstra, cofounder...
